Priority Date: 11.09.03 (DE 2003142108)

Base-substituted benzylamine analogs for use as coagulation factor Xa inhibitors, the production and use thereof

  • Application ID: EP10013066
  • Status: The application is deemed to be withdrawn



operating since 2003
Headquarter in Mannheim and 4 offices
active in Legal Services and IP Consulting


This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Isenbruck Bösl Hörschler LLP is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 227 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.


  • 11.09.2003 - Priority Date (DE 2003142108)
  • 09.03.2011 - Publication A2 (EP2292640)